Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 2Phase 2 1Phase 1 1

Status

Completed 5Unknown 1

Sponsor Class

OTHER 9INDUSTRY 6NIH 1

Study Type

Interventional 6

Sponsor

Cancer Type

Other 1

Conditions

Neoplasms 9Cancer Pain 9Pain 6Bronchiolitis Obliterans Syndrome 2Osteoarthritis 1Non Cancer Pain 1Lymphoma, Follicular 1Constipation 1Back Pain 1

Interventions

Fentanyl 13Zoledronic Acid 8Ibandronic Acid 8nabiximols 6Oxycodone 6Tapentadol 5Morphine 4Hydromorphone 4Cryotherapy 4Cryosurgery 4alvimopan 3trimebutine 3-thiocarbamoylbenzenesulfonate 2resiniferatoxin 2cabozantinib 2Tetrodotoxin 2Radiation 2Prednisone 2Naloxone 2Diclofenac 2Analgesics, Opioid 26'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2ziconotide 1oxycodone naloxone combination 1imisopasem manganese 1fulranumab 1Xylitol 1Ultracet 1Transdermal Patch 1Therapeutics 1Sufentanil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
INDUSTRY × Pain × Oxycodone × Clear all
NCT03176121 2020-03-18

STOP Pain

Taiwan Mundipharma Pharmaceuticals Ltd.

Phase 4 Completed
73 enrolled

Cancer Pain, Neoplasms, Pain

NCT03176199 2020-03-18

A Study to Compare the Titration Efficacy and Safety of Control-released Oxycodone and Immediate-released Oxycodone in Patients With Moderate to Severe Cancer Pain

Taiwan Mundipharma Pharmaceuticals Ltd.

Phase 4 Completed
30 enrolled

Cancer Pain, Neoplasms, Pain

NCT01885182 2019-10-04

Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer Pain

Mundipharma (China) Pharmaceutical Co. Ltd

Phase 3 Completed
232 enrolled 16 charts

Neoplasms, Pain

NCT00513656 2018-10-23

A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer Pain

Mundipharma Research GmbH & Co KG

Phase 2 Completed
230 enrolled
Other

Bronchiolitis Obliterans Syndrome, Constipation, Neoplasms, Pain

NCT01482936 2015-08-11

Pharmacokinetic (PK) Study of OxyNorm Injections in Chinese Patient

Mundipharma (China) Pharmaceutical Co. Ltd

Phase 1 Completed
44 enrolled

Pain

NCT00822614 2009-01-14

FINDS

Akela Pharma, Inc.

Phase 3 Unknown
500 enrolled

Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡